Formulation and characterization of α-tocopherol loaded poly ɛ-caprolactone (PCL) nanoparticles

LWT

Volumn 44, Issue 1, 2011, Pages 24-28

  Byun, Youngjae ^a   Hwang, Jin Bong ^b   Bang, Sung Hwan ^c   Darby, Duncan ^a   Cooksey, Kay ^a   Dawson, Paul L ^a   Park, Hyun Jin ^a,c   Whiteside, Scott ^a  

^a CLEMSON UNIVERSITY   (United States)

^b Korea Food Research Institute   (South Korea)

^c Korea University   (South Korea)

Author keywords

Antioxidant; Emulsion; Polycaprolactone; Ultrasonification; tocopherol

Indexed keywords

EFFICIENCY; EMULSIFICATION; ENCAPSULATION; NANOPARTICLES; ORGANIC SOLVENTS; POLYCAPROLACTONE;

CAPROLACTONE; EMULSION SOLVENT EVAPORATION; ENCAPSULATION EFFICIENCY; LARGE PARTICLES; MEAN SIZE; OIL PHASE; ULTRASONIFICATION; Α-TOCOPHEROL;

DICHLOROMETHANE;

EID: 77956874512     PISSN: 00236438     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lwt.2010.06.032     Document Type: Article

References (20)

1. Blander G., Oliveira R.M., Conboy C.M., Haigis M., Guarente L. Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. The Journal of Biological Chemistry 2003, 278:38966-38969.
2. Combs G.F. The vitamins: fundamental aspects in nutrition and health 2008, Elsevier Academic Press, London.
3. Forrest M., Zhao A., Won C., Malick A., Kwon G. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(e{open}-caprolactone) micelles. Journal of Controlled Release 2006, 116:139-149.
4. Govender T., Stolnik S., Garnett M., Illum L., Davis S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. Journal of Controlled Release 1999, 57:171-185.
5. Harman D. Free radical involvement in aging, pathophysiology and therapeutic implications. Drugs and Aging 1993, 3:60-80.
6. Ito F., Fujimori H., Makino K. Incorporation of water-soluble drugs in PLGA microspheres. Colloids and Surfaces B: Biointerfaces 2007, 54:173-178.
7. Kim B.K., Hwang S.J., Park J.B., Park H.J. Characteristics of felodipine-located poly(e{open}-caprolactone) microspheres. Journal of Microencapsulation 2005, 22:193-203.
8. Konan Y., Gurny R., Allemann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. International Journal of Pharmaceutics 2002, 233:239-252.
9. Leo E., Brina B., Forni F., Vandelli M. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. International Journal of Pharmaceutics 2004, 278:133-141.
10. Lien E., Ren S., Bui H., Wang R. Quantitative structure-activity relationship analysis of phenolic antioxidants. Free Radical Biology and Medicine 1999, 26:285-294.
11. Luong-Van E., Grondahl L., Nurcombe V., Cool S. In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 2007, 28:2127-2136.
12. Maia J., Santana M. The effect of some processing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process. Brazilian Journal of Chemical Engineering 2004, 21:1-12.
13. Mccarron P., Donnelly R., Marouf W. Celecoxib-loaded poly(d, l-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure. Journal of Microencapsulation 2006, 23:480-498.
14. Mora-Huertas C., Fessi H., Elaissari A. Polymer-based nanocapsules for drug delivery. International Journal of Pharmaceutics 2010, 385:113-142.
15. Pitt C.G. Poly e{open}-caprolactone and its copolymer. Biodegradable polymers as drug delivery systems 1990, 71-120. Marcel Dekker, New York. M. Chasin, R. Lange (Eds.).
16. Reis C., Neufeld R., Ribeiro A., Veiga F. Nanoencapsulation 1. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 2006, 2:8-21.
17. Sahoo S., Panyam J., Prabha S., Labhasetwar V. Residual polyvinyl alcohol associated with poly(d, l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release 2002, 82:105-114.
18. Scholes P., Coombes A., Illum L., Davis S., Vert M., Davies M. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. Journal of Controlled Release 1993, 25:145-153.
19. Song X., Zhao Y., Wu W., Bi Y., Cai Z., Chen Q., et al. PLGA nanoparticle simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. International Journal of Pharmaceutics 2008, 350:320-329.
20. Valko M., Leibfritz D., Moncol J., Cronin M., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry and Cell Biology 2007, 39:44-84.